Jason Brayer

4.2k citations

67 papers · 3.2k indexed · 1 hit paper · h-index 25

Impact in

Immunology top 1%
- Immune Cell Function and Interaction
- Immune cells in cancer
- Immunotherapy and Immune Responses
- Immune Response and Inflammation
Oncology top 2%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers

Papers in

Hematology 23
- Multiple Myeloma Research and Treatments 17
Immunology 26
- Immune Cell Function and Interaction 12
- Immunotherapy and Immune Responses 11

Co-authors: Eduardo M. Sotomayor Michael G. Humphreys‐Beher Alberto Delgado Paulo C. Rodrı́guez Augusto C. Ochoa Arnold H. Zea Scott Antonia David Quiceno
Journals: Blood (22 papers)Journal of Clinical Oncology (4 papers)Scandinavian Journal of Immunology (3 papers)Immunology Letters (2 papers)Proceedings of the National Academy of Sciences (2 papers)
Partner nations: United States Belgium Norway

In The Last Decade

Jason Brayer

67 papers receiving 3.2k citations

Hit Papers

align trajectories log scale

Arginase I Production in the Tumor Microenvironment by Mature Myeloid Cells Inhibits T-Cell Receptor Expression and Antigen-Specific T-Cell Responses 2004 · 974 citations

Peers

Countries citing papers authored by Jason Brayer

Since Specialization

Citations

This map shows the geographic impact of Jason Brayer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason Brayer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason Brayer more than expected).

Fields of papers citing papers by Jason Brayer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jason Brayer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason Brayer. The network helps show where Jason Brayer may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Jason Brayer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jason Brayer Line = papers co-authored together Jason Brayer links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Survivin Dendritic Cell Vaccine Safely Induces Immune Responses and Is Associated with Durable Disease Control after Autologous Transplant in Patients with Myeloma Clinical Cancer Research ·Ciara L. Freeman, Meaghen Hagarty, A. Joni Munarso, Meghan Menges, Jeffrey Edelman, Rachid Baz, Jason Brayer, Omar Castañeda Puglianini, José L. Ochoa-Bayona, Taiga Nishihori, Kenneth H. Shain, Bijal Shah, Dung‐Tsa Chen, Linda Kelley, Domenico Coppola, Melissa Alsina, Karunia Bayu Medita Satriani, Claudio Anasetti, Frederick L. Locke	2023	8
2	CYAD-01, an autologous NKG2D-based CAR T-cell therapy, in relapsed or refractory acute myeloid leukaemia and myelodysplastic syndromes or multiple myeloma (THINK): haematological cohorts of the dose escalation segment of a phase 1 trial The Lancet Haematology ·David A. Sallman, Tessa Kerre, Violaine Havelange, Xavier Poiré, Philippe Lewalle, Eunice S. Wang, Jason Brayer, Marco L. Davila, Ine Moors, Jean‐Pascal Machiels, Ahmad Awada, Erik Alcantar-Orozco, N. Shashidhar, Nathalie Braun, Maugan De Murcia, David E. Gilham, Caroline Lonez, Frédéric Lehmann, L. W. E. Rauwenhoff	2023	67
3	Early, Deep, and Durable Responses, and Low Rates of Cytokine Release Syndrome with REGN5458, a BCMAxCD3 Bispecific Monoclonal Antibody, in a Phase 1/2 First-in-Human Study in Patients with Relapsed/Refractory Multiple Myeloma (RRMM) Blood ·Jeffrey A. Zonder, Joshua Richter, Naresh Bumma, Jason Brayer, James E. Hoffman, William Bensinger, Ka Lung Wu, Linzhi Xu, Liang Yongme, Anita Boyapati, Manish Sharma, Karen Rodriguez Lorenc, Glenn S. Kroog, Madhav V. Dhodapkar, Suzanne Lentzsch, Dennis Cooper, Sundar Jagannath	2021	27
4	High-Dimensional Flow Cytometry Analysis of Regulatory Receptors on Human T Cells, NK Cells, and NKT Cells Methods in molecular biology ·J. B. Roberts, Jason Brayer, Nicole Restrepo, James J. Mulé, Adam W. Mailloux	2020	3
5	Phase I/II Study of Liposomal Doxorubicin (DOX) in Combination with Selinexor (SEL) and Dexamethasone (Dex) for Relapsed and Refractory Multiple Myeloma (RRMM) Blood ·Rachid Baz, Jeffrey A. Zonder, Kenneth H. Shain, Melissa Alsina, Jason Brayer, Mika Reivinen, Joel G. Turner, Jana L. Dawson, Jongphil Kim, Daniel M. Sullivan	2017	7
6	Study protocol for THINK: a multinational open-label phase I study to assess the safety and clinical activity of multiple administrations of NKR-2 in patients with different metastatic tumour types BMJ Open ·Caroline Lonez, Bikash Verma, Alain Hendlisz, Philippe Aftimos, Ahmad Awada, Eric Van Den Neste, Patricio Capelo Pontón, Jean‐Pascal Machiels, Fanny Piette, Jason Brayer, David A. Sallman, Tessa Kerre, Kunle Odunsi, Marco L. Davila, David E. Gilham, Frédéric Lehmann	2017	42
7	HDAC11 Is a Candidate Therapeutic Target in Multiple Myeloma Blood ·Jason Brayer, Allison Distler, Mark B. Meads, Eva Sahakian, John J. Powers, Tuan Nguyen, Melissa Alsina, Taiga Nishihori, Rachid Baz, Javier Pinilla‐Ibarz, Eduardo M. Sotomayor, JiaMing Lei	2017	1
8	The potential of ixazomib, a second-generation proteasome inhibitor, in the treatment of multiple myeloma Therapeutic Advances in Hematology ·Jason Brayer, Rachid Baz	2017	17
9	Developing Strategies in the Immunotherapy of Leukemias Cancer Control ·Jason Brayer, Javier Pinilla‐Ibarz	2013	12
10	TLR5 ligation by flagellin converts tolerogenic dendritic cells into activating antigen-presenting cells that preferentially induce T-helper 1 responses Immunology Letters ·A.S. Korotkov, Jason Brayer, Alejandro Villagra, Fengdong Cheng, Eduardo M. Sotomayor	2009	43
11	Expansion of Myeloid Suppressor Cells in SHIP-Deficient Mice Represses Allogeneic T Cell Responses The Journal of Immunology ·Tomar Ghansah, Kim H.T. Paraiso, Steven L. Highfill, Caroline Desponts, 曹珉桦, P. Vernoux, Tiffany R Turner, John M. Ninos, Jason Brayer, Fengdong Cheng, Eduardo M. Sotomayor, William G. Kerr	2004	87
12	A Dual Role for Interferon‐γ in the Pathogenesis of Sjögren's Syndrome‐Like Autoimmune Exocrinopathy in the Nonobese Diabetic Mouse Scandinavian Journal of Immunology ·Seunghee Cha, Jason Brayer, Juehua Gao, Willams Alex Murillo Oporto, Pratibha Subhashchandra Patankar, Anne Baird, A. B. Peck	2004	133
13	Arginase I Production in the Tumor Microenvironment by Mature Myeloid Cells Inhibits T-Cell Receptor Expression and Antigen-Specific T-Cell Responses Cancer Research ·Paulo C. Rodrı́guez, David Quiceno, Jovanny Zabaleta, Blair Ortiz, Arnold H. Zea, M. Blanca Piazuelo, Alberto Delgado, Pelayo Correa, Jason Brayer, Eduardo M. Sotomayor, Scott Antonia, Juan B. Ochoa, Augusto C. Ochoa Hit paper breakdown →	2004	974
14	Immunogenetics of Autoimmune Exocrinopathy in the Nod Mouse: More Than Meets the Eye Advances in experimental medicine and biology ·Michael G. Humphreys‐Beher, Jason Brayer, Seunghee Cha, Hiroyuki Nagashima, 刘南南, A. B. Peck	2002	5
15	Abnormal Organogenesis in Salivary Gland Development May Initiate Adult Onset of Autoimmune Exocrinopathy PubMed ·Seunghee Cha, a Spadafor, Marjan A. Versnel, Françoise Homo‐Delarche, Hiroyuki Nagashima, Jason Brayer, Ammon B. Peck, Michael G. Humphreys‐Beher	2001	44
16	IL‐4‐Dependent Effector Phase in Autoimmune Exocrinopathy as Defined by the NOD.IL‐4‐Gene Knockout Mouse Model of Sjögren's Syndrome Scandinavian Journal of Immunology ·Jason Brayer, Seunghee Cha, Hiroyuki Nagashima, Anne Baird, Anders Lindberg, 刘南南, Fethi Hammadi, Yue Chen, Michael G. Humphreys‐Beher, A. B. Peck	2001	75
17	Elevated proapoptotic Bax and caspase 3 activation in the NOD.scid model of Sj�gren's syndrome Arthritis & Rheumatism ·Sarah Janicki Hsieh, Alison Bean, Norman Talal, Pulido Sierra, Ibtisam Al‐Hashimi, Sylvia Shawcross, 麻理子河内, Ammon B. Peck, Jason Brayer, Michael G. Humphreys‐Beher, Howard Dang	2001	25
18	Differential absorption and distribution of epidermal growth factor and insulin-like growth factor in diabetic NOD mice Journal of Diabetes and its Complications ·Tsung-Chen Lee, Jason Brayer, Claudia Cacia, Hiroyuki Nagashima, Seunghee Cha, Gregory E. Oxford, Hyunho Yun, Ammon B. Peck, T Zelles, Michael G. Humphreys‐Beher	2001	4
19	Evidence for antimuscarinic acetylcholine receptor antibody-mediated secretory dysfunction in NOD mice Arthritis & Rheumatism ·Kim Nguyen, Jason Brayer, Seunghee Cha, 刘南南, Anne Baird, George Hilal, Ammon B. Peck, Michael G. Humphreys‐Beher	2000	101
20	Gastrointestinal absorption of insulin-like growth factor in the mouse in the absence of salivary insulin-like growth factor binding protein Biochemical Pharmacology ·Yoichi Nakagawa, Gregory E. Oxford, Katsunori Ishibashi, Hideo Yamamoto, Nobuko Maeda, E. T. W. Bowen, Jason Brayer, Michael G. Humphreys‐Beher	1997	6

About Jason Brayer

Jason Brayer is a scholar working on Hematology, Immunology, Oncology, Physiology and Genetics, having authored 67 papers that have together received 3.2k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (17 papers), Salivary Gland Disorders and Functions (17 papers), CAR-T cell therapy research (16 papers), Immune Cell Function and Interaction (12 papers), Immunotherapy and Immune Responses (11 papers), Protein Degradation and Inhibitors (10 papers), Diabetes and associated disorders (8 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). The work is most often cited by research in Immunology (1.7k citations), Oncology (1.2k citations), Hematology (388 citations), Physiology (846 citations) and Immunology and Allergy (134 citations). Jason Brayer has collaborated with scholars based in United States, Belgium and Norway. Frequent co-authors include Eduardo M. Sotomayor, Michael G. Humphreys‐Beher, Alberto Delgado, Paulo C. Rodrı́guez, Augusto C. Ochoa, Arnold H. Zea, Scott Antonia, David Quiceno, Pelayo Correa and Blair Ortiz. Their work appears in journals such as Blood, Journal of Clinical Oncology, Scandinavian Journal of Immunology, Immunology Letters and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact